114 related articles for article (PubMed ID: 21810091)
1. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
2. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
3. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
Wang N; Kim HG; Cotta CV; Wan M; Tang Y; Klug CA; Cao X
EMBO J; 2006 Apr; 25(7):1469-80. PubMed ID: 16525506
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with NUP98::HOXA9 mimicking acute promyelocytic leukemia.
Lin E; Chen W
Blood; 2023 Nov; 142(21):1845. PubMed ID: 37995102
[No Abstract] [Full Text] [Related]
6. Rare NUP98::PRRX1 fusion transcript in a therapy-related acute myeloid leukemia associated with del(7q) following chemotherapy for diffuse large B-cell lymphoma.
Wang Y; Zhang Z; Wang L; Wang H; Dong F
Cancer Genet; 2024 Jun; 284-285():12-15. PubMed ID: 38493578
[TBL] [Abstract][Full Text] [Related]
7. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
[TBL] [Abstract][Full Text] [Related]
9. Phase separation drives aberrant chromatin looping and cancer development.
Ahn JH; Davis ES; Daugird TA; Zhao S; Quiroga IY; Uryu H; Li J; Storey AJ; Tsai YH; Keeley DP; Mackintosh SG; Edmondson RD; Byrum SD; Cai L; Tackett AJ; Zheng D; Legant WR; Phanstiel DH; Wang GG
Nature; 2021 Jul; 595(7868):591-595. PubMed ID: 34163069
[TBL] [Abstract][Full Text] [Related]
10. HOXA9 has the hallmarks of a biological switch with implications in blood cancers.
Talarmain L; Clarke MA; Shorthouse D; Cabrera-Cosme L; Kent DG; Fisher J; Hall BA
Nat Commun; 2022 Oct; 13(1):5829. PubMed ID: 36192425
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9.
Zhang M; Hyle J; Chen X; Xin Y; Jin Y; Zhang J; Yang X; Chen X; Wright S; Liu Z; Rosikiewicz W; Xu B; He L; Liu H; Ping N; Wu D; Wen F; Li C; Xu P
Genome Biol; 2024 Jan; 25(1):16. PubMed ID: 38216972
[TBL] [Abstract][Full Text] [Related]
12. Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia.
Olme CH; Finnon R; Brown N; Kabacik S; Bouffler SD; Badie C
Leuk Res; 2013 Oct; 37(10):1374-82. PubMed ID: 23806234
[TBL] [Abstract][Full Text] [Related]
13. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract][Full Text] [Related]
14. HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia.
Agrawal-Singh S; Bagri J; Giotopoulos G; Azazi DMA; Horton SJ; Lopez CK; Anand S; Bach AS; Stedham F; Antrobus R; Houghton JW; Vassiliou GS; Sasca D; Yun H; Whetton AD; Huntly BJP
Blood; 2023 Apr; 141(14):1737-1754. PubMed ID: 36577137
[TBL] [Abstract][Full Text] [Related]
15. Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy.
Conneely SE; Stevens AM
Curr Oncol Rep; 2021 Jan; 23(2):16. PubMed ID: 33439382
[TBL] [Abstract][Full Text] [Related]
16. Novel ZFPL1::NUP98 fusion gene identified in an adult acute myeloid leukemia patient.
Zhu Y; Chen Y; Zhang F; Wang M; Lai Y; Pan J; Liu Y; Wang Q; Chen S
Int J Lab Hematol; 2024 Jun; 46(3):568-570. PubMed ID: 38318992
[No Abstract] [Full Text] [Related]
17. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
Michmerhuizen NL; Klco JM; Mullighan CG
Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study.
Heald JS; López AM; Pato ML; Ruiz-Xivillé N; Cabezón M; Zamora L; Vives S; Coll R; Maluquer C; Granada I; Solé F; Esteller M; Berdasco M
Blood Adv; 2024 Jun; 8(11):2691-2694. PubMed ID: 38536941
[No Abstract] [Full Text] [Related]
19. Retroviral insertional mutagenesis identifies oncogene cooperation.
Nakamura T
Cancer Sci; 2005 Jan; 96(1):7-12. PubMed ID: 15649248
[TBL] [Abstract][Full Text] [Related]
20. Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.
Lambert M; Jambon S; Bouhlel MA; Depauw S; Vrevin J; Blanck S; Marot G; Figeac M; Preudhomme C; Quesnel B; Boykin DW; David-Cordonnier MH
Hemasphere; 2024 May; 8(5):e77. PubMed ID: 38716146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
